Chin L. Tan

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoire.

Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoire.

Journal: Science advances

Published: April 10, 2026

ESPEC-SUIT: a versatile and robust platform to identify and track antigen-specific T cell receptors in patients with cancer.

ESPEC-SUIT: a versatile and robust platform to identify and track antigen-specific T cell receptors in patients with cancer.

Journal: Journal for immunotherapy of cancer

Published: July 30, 2025

H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient.

H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient.

Journal: Science advances

Published: February 02, 2024

Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target.

Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target.

Journal: Nature communications

Published: January 29, 2024

Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic cancer.

Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic cancer.

Journal: Science translational medicine

Published: November 15, 2023

Cranioencephalic functional lymphoid units in glioblastoma.

Cranioencephalic functional lymphoid units in glioblastoma.

Journal: Nature medicine

Published: June 26, 2023

Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy.

Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy.

Journal: Nature biotechnology

Published: June 13, 2023

Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model.

Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model.

Journal: Frontiers in immunology

Published: November 11, 2022

Endothelial Indoleamine-2,3-Dioxygenase-1 is not Critically Involved in Regulating Antitumor Immunity in the Central Nervous System.

Endothelial Indoleamine-2,3-Dioxygenase-1 is not Critically Involved in Regulating Antitumor Immunity in the Central Nervous System.

Journal: International journal of tryptophan research : IJTR

Published: October 19, 2022

MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors.

MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors.

Journal: Cancer cell

Published: May 10, 2022

Common T-Cell-Receptor Motifs and Features in Patients with Cytomegalovirus (CMV)-Seronegative End-Stage Renal Disease Receiving a Peptide Vaccination against CMV.

Common T-Cell-Receptor Motifs and Features in Patients with Cytomegalovirus (CMV)-Seronegative End-Stage Renal Disease Receiving a Peptide Vaccination against CMV.

Journal: International journal of molecular sciences

Published: December 01, 2021

Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes.

Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes.

Journal: Neuro-oncology advances

Published: November 05, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026